Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris’ Corner

Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow the company to bring leading innovative products to the Canadian market. Tune in!

Featured Content, Health Science, Pharmaceuticals, Series, Video

Related Posts

Valeo Pharma (VPH.C) gets their Hesperco flavonoid medicine on shelves with Loblaws brand

Valeo Pharma Inc. (VPH.C) Enters PLA with Quebec Minister of Health

Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth

To Invest or Not: Valeo Pharma (VPH.C)

Chart Attack: Valeo Pharma (VPH.C) Finds Buyers and Holds the Uptrend

Valeo Pharma (VPH.C) – Investor Roundtable #3

More on VPH.C

Valeo Pharma (VPH.C) gets their Hesperco flavonoid medicine on shelves with Loblaws brand

Valeo Pharma Inc. (VPH.C) Enters PLA with Quebec Minister of Health

Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth

To Invest or Not: Valeo Pharma (VPH.C)

Chart Attack: Valeo Pharma (VPH.C) Finds Buyers and Holds the Uptrend

Valeo Pharma (VPH.C) – Investor Roundtable #3

Leave a Reply Cancel reply